• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gegen Huazhuo Tang (GHT)抑制7-KDCA并增加TGR5以促进白色脂肪棕色化。

Gegen Huazhuo Tang (GHT) inhibits 7-KDCA and increases TGR5 to promote white fat browning.

作者信息

Ni Xintao, Cheng Siyao, Jin Xiaoqin, Sun Yunxia, Yang Zhenggang, Hu Miaofen G, Hou Xiaoli

机构信息

School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China; College of Basic Medical Sciences, Zhejiang Chinese Medical University, China.

Academy of Chinese Medical Science, Zhejiang Chinese Medical University, China.

出版信息

J Ethnopharmacol. 2025 Jul 7;352:120266. doi: 10.1016/j.jep.2025.120266.

DOI:10.1016/j.jep.2025.120266
PMID:40633859
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Gegen Huazhuo Tang (GHT), an empirical clinical prescription for treating hyperlipidemia in China, is composed of five herbs with both medicine and food uses and one functional food derived from traditional medicine, all of which exhibit hypolipidemic and anti-obesity effects. However, ingredients and pharmacological mechanism of GHT remains unexplored.

AIM OF THE STUDY

We investigated the role of GHT on high-fat diet (HFD)-induced obesity and its molecular regulation on adipose thermogenesis.

METHODS

The ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS) was used to identify components of GHT and metabolites in GHT-containing serum (GHTS) from GHT-treated rats. In vivo, six-week-old male C57BL/6J mice were randomly assigned to control (distilled water) and GHT (13 g/kg/day via gavage) groups fed either a normal chow diet (NCD) or HFD for 12 weeks. In vitro, adipocytes differentiated from inguinal white adipose tissue (iWAT)-isolated stromal vascular fraction (SVF) cells and 3T3-L1 preadipocytes were used to evaluate the effect of GHTS metabolites on thermogenesis.

RESULTS

Thirteen chemical components were identified in GHT and eleven differential metabolites were confirmed in GHTS. GHT prevented obesity through increasing white fat browning via the parallel recruitment of UCP1-dependent and UCP1-independent (sarco/endoplasmic reticulum Ca-ATPase 1, SERCA1 and mitochondrial creatine kinase 2, CKMT2) systems. GHT reduced serum 7-ketodeoxycholic acid (7-KDCA) levels, thereby activating adipose Takeda G protein-coupled receptor 5 (TGR5) and downstream AMPK signaling pathways to promote thermogenic beige adipocyte formation. Correspondingly, following the addition of 7-KDCA, the expressions of UCP1-dependent and UCP1-independent browning markers in mature adipocytes were inhibited via suppressing TGR5-AMPK.

CONCLUSIONS

These findings demonstrate that GHT reduces serum 7-KDCA and consequently activates TGR5-AMPK signaling to induce UCP1-dependent and UCP1-independent thermogenesis in white adipose tissue and protect against obesity.

摘要

民族药理学相关性

葛根化浊汤(GHT)是中国用于治疗高脂血症的经验性临床处方,由五种药食两用的草药和一种源自传统医学的功能性食品组成,所有这些成分均具有降血脂和抗肥胖作用。然而,GHT的成分和药理机制仍未得到探索。

研究目的

我们研究了GHT对高脂饮食(HFD)诱导的肥胖的作用及其对脂肪产热的分子调节作用。

方法

采用超高效液相色谱-四极杆飞行时间质谱联用技术(UPLC-Q/TOF-MS)鉴定GHT的成分以及GHT处理大鼠含药血清(GHTS)中的代谢产物。在体内,将六周龄雄性C57BL/6J小鼠随机分为对照组(蒸馏水)和GHT组(通过灌胃给予13 g/kg/天),分别给予正常饲料(NCD)或HFD喂养12周。在体外,使用从腹股沟白色脂肪组织(iWAT)分离的基质血管成分(SVF)细胞和3T3-L1前脂肪细胞分化而来的脂肪细胞来评估GHTS代谢产物对产热的影响。

结果

在GHT中鉴定出13种化学成分,在GHTS中确认了11种差异代谢产物。GHT通过平行募集UCP1依赖性和UCP1非依赖性(肌浆网/内质网Ca-ATP酶1,SERCA1和线粒体肌酸激酶2,CKMT2)系统增加白色脂肪褐变,从而预防肥胖。GHT降低血清7-酮脱氧胆酸(7-KDCA)水平,从而激活脂肪组织中的武田G蛋白偶联受体5(TGR5)和下游AMPK信号通路,促进产热米色脂肪细胞的形成。相应地,添加7-KDCA后,通过抑制TGR5-AMPK抑制成熟脂肪细胞中UCP1依赖性和UCP1非依赖性褐变标记物的表达。

结论

这些发现表明,GHT可降低血清7-KDCA水平,从而激活TGR5-AMPK信号,诱导白色脂肪组织中UCP1依赖性和UCP1非依赖性产热,预防肥胖。

相似文献

1
Gegen Huazhuo Tang (GHT) inhibits 7-KDCA and increases TGR5 to promote white fat browning.Gegen Huazhuo Tang (GHT)抑制7-KDCA并增加TGR5以促进白色脂肪棕色化。
J Ethnopharmacol. 2025 Jul 7;352:120266. doi: 10.1016/j.jep.2025.120266.
2
Adipose-specific HuR deletion protects against high-fat diet-induced obesity in mice through upregulating Ucp1 expression.脂肪组织特异性HuR缺失通过上调Ucp1表达来保护小鼠免受高脂饮食诱导的肥胖。
Lipids Health Dis. 2025 Aug 25;24(1):264. doi: 10.1186/s12944-025-02680-w.
3
4-hydroxybenzoic acid induces browning of white adipose tissue through the AMPK-DRP1 pathway in HFD-induced obese mice.4-羟基苯甲酸通过AMPK-DRP1途径诱导高脂饮食诱导的肥胖小鼠白色脂肪组织褐变。
Phytomedicine. 2025 Feb;137:156353. doi: 10.1016/j.phymed.2024.156353. Epub 2024 Dec 27.
4
Exosome-Derived miR-11987 in Bovine Milk Inhibits Obesity Through Browning of White Fat.牛乳中源自外泌体的miR-11987通过白色脂肪棕色化抑制肥胖。
Int J Mol Sci. 2025 Jun 23;26(13):6006. doi: 10.3390/ijms26136006.
5
Dapagliflozin promotes white adipose tissue browning though regulating angiogenesis in high fat induced obese mice.达格列净通过调节高脂诱导肥胖小鼠的血管生成促进白色脂肪组织褐变。
BMC Pharmacol Toxicol. 2024 Mar 19;25(1):26. doi: 10.1186/s40360-024-00747-5.
6
BAP1 Suppresses White Adipose Tissue Browning and Thermogenesis Through Deubiquitinating KDM1B.BAP1通过去泛素化KDM1B抑制白色脂肪组织褐变和产热。
Diabetes. 2025 Jul 1;74(7):1153-1167. doi: 10.2337/db24-1011.
7
S100A8/S100A9 impairs energy expenditure and whole body metabolism.S100A8/S100A9会损害能量消耗和全身代谢。
Am J Physiol Endocrinol Metab. 2025 Aug 1;329(2):E341-E354. doi: 10.1152/ajpendo.00076.2025. Epub 2025 Jul 15.
8
Ablation of FAM210A in Brown Adipocytes of Mice Exacerbates High-Fat Diet-Induced Metabolic Dysfunction.小鼠棕色脂肪细胞中FAM210A的缺失加剧了高脂饮食诱导的代谢功能障碍。
Diabetes. 2025 Mar 1;74(3):282-294. doi: 10.2337/db24-0294.
9
Cold-Pressed Oil Standardized to 3% Thymoquinone Potentiates Omega-3 Protection against Obesity-Induced Oxidative Stress, Inflammation, and Markers of Insulin Resistance Accompanied with Conversion of White to Beige Fat in Mice.标准化为含3%百里醌的冷榨油增强了ω-3对肥胖诱导的氧化应激、炎症和胰岛素抵抗标志物的保护作用,并伴随着小鼠白色脂肪向米色脂肪的转变。
Antioxidants (Basel). 2020 Jun 4;9(6):489. doi: 10.3390/antiox9060489.
10
Adipose tissue-targeted drug delivery for treating obesity: current opportunities and challenges.用于治疗肥胖症的脂肪组织靶向药物递送:当前机遇与挑战
Drug Deliv. 2025 Dec;32(1):2547751. doi: 10.1080/10717544.2025.2547751. Epub 2025 Aug 22.